How much of a problem is too much saliva for patients following head and neck cancer
The aim of this paper is to report the clinical characteristic of those patients reporting “I have too much saliva” following treatment for head and neck cancer. As a new addition to the saliva question of the University of Washington quality of life questionnaire (UW-QoL), another aim is to make re...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Broderick, Damian [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2020transfer abstract |
|---|
| Schlagwörter: |
|---|
| Umfang: |
6 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Bond durability of BFRP bars embedded in concrete under seawater conditions and the long-term bond strength prediction - Dong, Zhiqiang ELSEVIER, 2016transfer abstract, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:58 ; year:2020 ; number:9 ; pages:51-56 ; extent:6 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.bjoms.2020.05.033 |
|---|
| Katalog-ID: |
ELV052172236 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV052172236 | ||
| 003 | DE-627 | ||
| 005 | 20230626032928.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210910s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.bjoms.2020.05.033 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001214.pica |
| 035 | |a (DE-627)ELV052172236 | ||
| 035 | |a (ELSEVIER)S0266-4356(20)30257-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 600 |q VZ |
| 082 | 0 | 4 | |a 690 |q VZ |
| 100 | 1 | |a Broderick, Damian |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a How much of a problem is too much saliva for patients following head and neck cancer |
| 264 | 1 | |c 2020transfer abstract | |
| 300 | |a 6 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a The aim of this paper is to report the clinical characteristic of those patients reporting “I have too much saliva” following treatment for head and neck cancer. As a new addition to the saliva question of the University of Washington quality of life questionnaire (UW-QoL), another aim is to make recommendations on how this new option should be scored and handled. Patients treated with curative intent were recruited between April 2017 and October 2019. Assessment was at the first baseline clinic a median (IQR) of 194 (125–249) days after diagnosis and 103 (71–162) days after the end of treatment. Patients completed the modified UW-QoL version 4, the Patient Concerns Inventory (PCI), Distress Thermometer, and the EQ-5D-5L. In 288 patients, saliva was of normal consistency for 80 (28%), less than normal but enough for 57 (20%), too little for 91 (32%), too much for 45 (16%), and there was no saliva at all for 15 (5%). Of patients with too much saliva, two-thirds (31/45, 69%) had tumours located in the oral cavity and 18/40 (45%) had the highest rates of free flap use during surgery. Salivation response was associated strongly with the other measures of health-related quality of life (HRQoL) and the PCI. Of those with too much saliva their results were similar to or worse than those with too little or no saliva at all. In conclusion, having too much saliva is relatively less frequently reported but is an important HRQoL consideration. Its scoring in the UW-QoL should be at a level similar to that of too little saliva. | ||
| 520 | |a The aim of this paper is to report the clinical characteristic of those patients reporting “I have too much saliva” following treatment for head and neck cancer. As a new addition to the saliva question of the University of Washington quality of life questionnaire (UW-QoL), another aim is to make recommendations on how this new option should be scored and handled. Patients treated with curative intent were recruited between April 2017 and October 2019. Assessment was at the first baseline clinic a median (IQR) of 194 (125–249) days after diagnosis and 103 (71–162) days after the end of treatment. Patients completed the modified UW-QoL version 4, the Patient Concerns Inventory (PCI), Distress Thermometer, and the EQ-5D-5L. In 288 patients, saliva was of normal consistency for 80 (28%), less than normal but enough for 57 (20%), too little for 91 (32%), too much for 45 (16%), and there was no saliva at all for 15 (5%). Of patients with too much saliva, two-thirds (31/45, 69%) had tumours located in the oral cavity and 18/40 (45%) had the highest rates of free flap use during surgery. Salivation response was associated strongly with the other measures of health-related quality of life (HRQoL) and the PCI. Of those with too much saliva their results were similar to or worse than those with too little or no saliva at all. In conclusion, having too much saliva is relatively less frequently reported but is an important HRQoL consideration. Its scoring in the UW-QoL should be at a level similar to that of too little saliva. | ||
| 650 | 7 | |a EQ-5D |2 Elsevier | |
| 650 | 7 | |a Questionnaire |2 Elsevier | |
| 650 | 7 | |a UW-QOL |2 Elsevier | |
| 650 | 7 | |a Head and neck cancer |2 Elsevier | |
| 650 | 7 | |a Saliva |2 Elsevier | |
| 650 | 7 | |a Quality of life |2 Elsevier | |
| 700 | 1 | |a Lowe, Derek |4 oth | |
| 700 | 1 | |a Kanatas, Anastasios |4 oth | |
| 700 | 1 | |a N Rogers, Simon |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Dong, Zhiqiang ELSEVIER |t Bond durability of BFRP bars embedded in concrete under seawater conditions and the long-term bond strength prediction |d 2016transfer abstract |g Amsterdam [u.a.] |w (DE-627)ELV013958291 |
| 773 | 1 | 8 | |g volume:58 |g year:2020 |g number:9 |g pages:51-56 |g extent:6 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.bjoms.2020.05.033 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a GBV_ILN_40 | ||
| 951 | |a AR | ||
| 952 | |d 58 |j 2020 |e 9 |h 51-56 |g 6 |y 58.2020, 9, e51-, (6 S.) | ||
| author_variant |
d b db |
|---|---|
| matchkey_str |
broderickdamianlowederekkanatasanastasio:2020----:omcoarbeitouhaiaoptetfloi |
| hierarchy_sort_str |
2020transfer abstract |
| publishDate |
2020 |
| allfields |
10.1016/j.bjoms.2020.05.033 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001214.pica (DE-627)ELV052172236 (ELSEVIER)S0266-4356(20)30257-6 DE-627 ger DE-627 rakwb eng 600 VZ 690 VZ Broderick, Damian verfasserin aut How much of a problem is too much saliva for patients following head and neck cancer 2020transfer abstract 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The aim of this paper is to report the clinical characteristic of those patients reporting “I have too much saliva” following treatment for head and neck cancer. As a new addition to the saliva question of the University of Washington quality of life questionnaire (UW-QoL), another aim is to make recommendations on how this new option should be scored and handled. Patients treated with curative intent were recruited between April 2017 and October 2019. Assessment was at the first baseline clinic a median (IQR) of 194 (125–249) days after diagnosis and 103 (71–162) days after the end of treatment. Patients completed the modified UW-QoL version 4, the Patient Concerns Inventory (PCI), Distress Thermometer, and the EQ-5D-5L. In 288 patients, saliva was of normal consistency for 80 (28%), less than normal but enough for 57 (20%), too little for 91 (32%), too much for 45 (16%), and there was no saliva at all for 15 (5%). Of patients with too much saliva, two-thirds (31/45, 69%) had tumours located in the oral cavity and 18/40 (45%) had the highest rates of free flap use during surgery. Salivation response was associated strongly with the other measures of health-related quality of life (HRQoL) and the PCI. Of those with too much saliva their results were similar to or worse than those with too little or no saliva at all. In conclusion, having too much saliva is relatively less frequently reported but is an important HRQoL consideration. Its scoring in the UW-QoL should be at a level similar to that of too little saliva. The aim of this paper is to report the clinical characteristic of those patients reporting “I have too much saliva” following treatment for head and neck cancer. As a new addition to the saliva question of the University of Washington quality of life questionnaire (UW-QoL), another aim is to make recommendations on how this new option should be scored and handled. Patients treated with curative intent were recruited between April 2017 and October 2019. Assessment was at the first baseline clinic a median (IQR) of 194 (125–249) days after diagnosis and 103 (71–162) days after the end of treatment. Patients completed the modified UW-QoL version 4, the Patient Concerns Inventory (PCI), Distress Thermometer, and the EQ-5D-5L. In 288 patients, saliva was of normal consistency for 80 (28%), less than normal but enough for 57 (20%), too little for 91 (32%), too much for 45 (16%), and there was no saliva at all for 15 (5%). Of patients with too much saliva, two-thirds (31/45, 69%) had tumours located in the oral cavity and 18/40 (45%) had the highest rates of free flap use during surgery. Salivation response was associated strongly with the other measures of health-related quality of life (HRQoL) and the PCI. Of those with too much saliva their results were similar to or worse than those with too little or no saliva at all. In conclusion, having too much saliva is relatively less frequently reported but is an important HRQoL consideration. Its scoring in the UW-QoL should be at a level similar to that of too little saliva. EQ-5D Elsevier Questionnaire Elsevier UW-QOL Elsevier Head and neck cancer Elsevier Saliva Elsevier Quality of life Elsevier Lowe, Derek oth Kanatas, Anastasios oth N Rogers, Simon oth Enthalten in Elsevier Dong, Zhiqiang ELSEVIER Bond durability of BFRP bars embedded in concrete under seawater conditions and the long-term bond strength prediction 2016transfer abstract Amsterdam [u.a.] (DE-627)ELV013958291 volume:58 year:2020 number:9 pages:51-56 extent:6 https://doi.org/10.1016/j.bjoms.2020.05.033 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_40 AR 58 2020 9 51-56 6 58.2020, 9, e51-, (6 S.) |
| spelling |
10.1016/j.bjoms.2020.05.033 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001214.pica (DE-627)ELV052172236 (ELSEVIER)S0266-4356(20)30257-6 DE-627 ger DE-627 rakwb eng 600 VZ 690 VZ Broderick, Damian verfasserin aut How much of a problem is too much saliva for patients following head and neck cancer 2020transfer abstract 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The aim of this paper is to report the clinical characteristic of those patients reporting “I have too much saliva” following treatment for head and neck cancer. As a new addition to the saliva question of the University of Washington quality of life questionnaire (UW-QoL), another aim is to make recommendations on how this new option should be scored and handled. Patients treated with curative intent were recruited between April 2017 and October 2019. Assessment was at the first baseline clinic a median (IQR) of 194 (125–249) days after diagnosis and 103 (71–162) days after the end of treatment. Patients completed the modified UW-QoL version 4, the Patient Concerns Inventory (PCI), Distress Thermometer, and the EQ-5D-5L. In 288 patients, saliva was of normal consistency for 80 (28%), less than normal but enough for 57 (20%), too little for 91 (32%), too much for 45 (16%), and there was no saliva at all for 15 (5%). Of patients with too much saliva, two-thirds (31/45, 69%) had tumours located in the oral cavity and 18/40 (45%) had the highest rates of free flap use during surgery. Salivation response was associated strongly with the other measures of health-related quality of life (HRQoL) and the PCI. Of those with too much saliva their results were similar to or worse than those with too little or no saliva at all. In conclusion, having too much saliva is relatively less frequently reported but is an important HRQoL consideration. Its scoring in the UW-QoL should be at a level similar to that of too little saliva. The aim of this paper is to report the clinical characteristic of those patients reporting “I have too much saliva” following treatment for head and neck cancer. As a new addition to the saliva question of the University of Washington quality of life questionnaire (UW-QoL), another aim is to make recommendations on how this new option should be scored and handled. Patients treated with curative intent were recruited between April 2017 and October 2019. Assessment was at the first baseline clinic a median (IQR) of 194 (125–249) days after diagnosis and 103 (71–162) days after the end of treatment. Patients completed the modified UW-QoL version 4, the Patient Concerns Inventory (PCI), Distress Thermometer, and the EQ-5D-5L. In 288 patients, saliva was of normal consistency for 80 (28%), less than normal but enough for 57 (20%), too little for 91 (32%), too much for 45 (16%), and there was no saliva at all for 15 (5%). Of patients with too much saliva, two-thirds (31/45, 69%) had tumours located in the oral cavity and 18/40 (45%) had the highest rates of free flap use during surgery. Salivation response was associated strongly with the other measures of health-related quality of life (HRQoL) and the PCI. Of those with too much saliva their results were similar to or worse than those with too little or no saliva at all. In conclusion, having too much saliva is relatively less frequently reported but is an important HRQoL consideration. Its scoring in the UW-QoL should be at a level similar to that of too little saliva. EQ-5D Elsevier Questionnaire Elsevier UW-QOL Elsevier Head and neck cancer Elsevier Saliva Elsevier Quality of life Elsevier Lowe, Derek oth Kanatas, Anastasios oth N Rogers, Simon oth Enthalten in Elsevier Dong, Zhiqiang ELSEVIER Bond durability of BFRP bars embedded in concrete under seawater conditions and the long-term bond strength prediction 2016transfer abstract Amsterdam [u.a.] (DE-627)ELV013958291 volume:58 year:2020 number:9 pages:51-56 extent:6 https://doi.org/10.1016/j.bjoms.2020.05.033 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_40 AR 58 2020 9 51-56 6 58.2020, 9, e51-, (6 S.) |
| allfields_unstemmed |
10.1016/j.bjoms.2020.05.033 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001214.pica (DE-627)ELV052172236 (ELSEVIER)S0266-4356(20)30257-6 DE-627 ger DE-627 rakwb eng 600 VZ 690 VZ Broderick, Damian verfasserin aut How much of a problem is too much saliva for patients following head and neck cancer 2020transfer abstract 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The aim of this paper is to report the clinical characteristic of those patients reporting “I have too much saliva” following treatment for head and neck cancer. As a new addition to the saliva question of the University of Washington quality of life questionnaire (UW-QoL), another aim is to make recommendations on how this new option should be scored and handled. Patients treated with curative intent were recruited between April 2017 and October 2019. Assessment was at the first baseline clinic a median (IQR) of 194 (125–249) days after diagnosis and 103 (71–162) days after the end of treatment. Patients completed the modified UW-QoL version 4, the Patient Concerns Inventory (PCI), Distress Thermometer, and the EQ-5D-5L. In 288 patients, saliva was of normal consistency for 80 (28%), less than normal but enough for 57 (20%), too little for 91 (32%), too much for 45 (16%), and there was no saliva at all for 15 (5%). Of patients with too much saliva, two-thirds (31/45, 69%) had tumours located in the oral cavity and 18/40 (45%) had the highest rates of free flap use during surgery. Salivation response was associated strongly with the other measures of health-related quality of life (HRQoL) and the PCI. Of those with too much saliva their results were similar to or worse than those with too little or no saliva at all. In conclusion, having too much saliva is relatively less frequently reported but is an important HRQoL consideration. Its scoring in the UW-QoL should be at a level similar to that of too little saliva. The aim of this paper is to report the clinical characteristic of those patients reporting “I have too much saliva” following treatment for head and neck cancer. As a new addition to the saliva question of the University of Washington quality of life questionnaire (UW-QoL), another aim is to make recommendations on how this new option should be scored and handled. Patients treated with curative intent were recruited between April 2017 and October 2019. Assessment was at the first baseline clinic a median (IQR) of 194 (125–249) days after diagnosis and 103 (71–162) days after the end of treatment. Patients completed the modified UW-QoL version 4, the Patient Concerns Inventory (PCI), Distress Thermometer, and the EQ-5D-5L. In 288 patients, saliva was of normal consistency for 80 (28%), less than normal but enough for 57 (20%), too little for 91 (32%), too much for 45 (16%), and there was no saliva at all for 15 (5%). Of patients with too much saliva, two-thirds (31/45, 69%) had tumours located in the oral cavity and 18/40 (45%) had the highest rates of free flap use during surgery. Salivation response was associated strongly with the other measures of health-related quality of life (HRQoL) and the PCI. Of those with too much saliva their results were similar to or worse than those with too little or no saliva at all. In conclusion, having too much saliva is relatively less frequently reported but is an important HRQoL consideration. Its scoring in the UW-QoL should be at a level similar to that of too little saliva. EQ-5D Elsevier Questionnaire Elsevier UW-QOL Elsevier Head and neck cancer Elsevier Saliva Elsevier Quality of life Elsevier Lowe, Derek oth Kanatas, Anastasios oth N Rogers, Simon oth Enthalten in Elsevier Dong, Zhiqiang ELSEVIER Bond durability of BFRP bars embedded in concrete under seawater conditions and the long-term bond strength prediction 2016transfer abstract Amsterdam [u.a.] (DE-627)ELV013958291 volume:58 year:2020 number:9 pages:51-56 extent:6 https://doi.org/10.1016/j.bjoms.2020.05.033 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_40 AR 58 2020 9 51-56 6 58.2020, 9, e51-, (6 S.) |
| allfieldsGer |
10.1016/j.bjoms.2020.05.033 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001214.pica (DE-627)ELV052172236 (ELSEVIER)S0266-4356(20)30257-6 DE-627 ger DE-627 rakwb eng 600 VZ 690 VZ Broderick, Damian verfasserin aut How much of a problem is too much saliva for patients following head and neck cancer 2020transfer abstract 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The aim of this paper is to report the clinical characteristic of those patients reporting “I have too much saliva” following treatment for head and neck cancer. As a new addition to the saliva question of the University of Washington quality of life questionnaire (UW-QoL), another aim is to make recommendations on how this new option should be scored and handled. Patients treated with curative intent were recruited between April 2017 and October 2019. Assessment was at the first baseline clinic a median (IQR) of 194 (125–249) days after diagnosis and 103 (71–162) days after the end of treatment. Patients completed the modified UW-QoL version 4, the Patient Concerns Inventory (PCI), Distress Thermometer, and the EQ-5D-5L. In 288 patients, saliva was of normal consistency for 80 (28%), less than normal but enough for 57 (20%), too little for 91 (32%), too much for 45 (16%), and there was no saliva at all for 15 (5%). Of patients with too much saliva, two-thirds (31/45, 69%) had tumours located in the oral cavity and 18/40 (45%) had the highest rates of free flap use during surgery. Salivation response was associated strongly with the other measures of health-related quality of life (HRQoL) and the PCI. Of those with too much saliva their results were similar to or worse than those with too little or no saliva at all. In conclusion, having too much saliva is relatively less frequently reported but is an important HRQoL consideration. Its scoring in the UW-QoL should be at a level similar to that of too little saliva. The aim of this paper is to report the clinical characteristic of those patients reporting “I have too much saliva” following treatment for head and neck cancer. As a new addition to the saliva question of the University of Washington quality of life questionnaire (UW-QoL), another aim is to make recommendations on how this new option should be scored and handled. Patients treated with curative intent were recruited between April 2017 and October 2019. Assessment was at the first baseline clinic a median (IQR) of 194 (125–249) days after diagnosis and 103 (71–162) days after the end of treatment. Patients completed the modified UW-QoL version 4, the Patient Concerns Inventory (PCI), Distress Thermometer, and the EQ-5D-5L. In 288 patients, saliva was of normal consistency for 80 (28%), less than normal but enough for 57 (20%), too little for 91 (32%), too much for 45 (16%), and there was no saliva at all for 15 (5%). Of patients with too much saliva, two-thirds (31/45, 69%) had tumours located in the oral cavity and 18/40 (45%) had the highest rates of free flap use during surgery. Salivation response was associated strongly with the other measures of health-related quality of life (HRQoL) and the PCI. Of those with too much saliva their results were similar to or worse than those with too little or no saliva at all. In conclusion, having too much saliva is relatively less frequently reported but is an important HRQoL consideration. Its scoring in the UW-QoL should be at a level similar to that of too little saliva. EQ-5D Elsevier Questionnaire Elsevier UW-QOL Elsevier Head and neck cancer Elsevier Saliva Elsevier Quality of life Elsevier Lowe, Derek oth Kanatas, Anastasios oth N Rogers, Simon oth Enthalten in Elsevier Dong, Zhiqiang ELSEVIER Bond durability of BFRP bars embedded in concrete under seawater conditions and the long-term bond strength prediction 2016transfer abstract Amsterdam [u.a.] (DE-627)ELV013958291 volume:58 year:2020 number:9 pages:51-56 extent:6 https://doi.org/10.1016/j.bjoms.2020.05.033 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_40 AR 58 2020 9 51-56 6 58.2020, 9, e51-, (6 S.) |
| allfieldsSound |
10.1016/j.bjoms.2020.05.033 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001214.pica (DE-627)ELV052172236 (ELSEVIER)S0266-4356(20)30257-6 DE-627 ger DE-627 rakwb eng 600 VZ 690 VZ Broderick, Damian verfasserin aut How much of a problem is too much saliva for patients following head and neck cancer 2020transfer abstract 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The aim of this paper is to report the clinical characteristic of those patients reporting “I have too much saliva” following treatment for head and neck cancer. As a new addition to the saliva question of the University of Washington quality of life questionnaire (UW-QoL), another aim is to make recommendations on how this new option should be scored and handled. Patients treated with curative intent were recruited between April 2017 and October 2019. Assessment was at the first baseline clinic a median (IQR) of 194 (125–249) days after diagnosis and 103 (71–162) days after the end of treatment. Patients completed the modified UW-QoL version 4, the Patient Concerns Inventory (PCI), Distress Thermometer, and the EQ-5D-5L. In 288 patients, saliva was of normal consistency for 80 (28%), less than normal but enough for 57 (20%), too little for 91 (32%), too much for 45 (16%), and there was no saliva at all for 15 (5%). Of patients with too much saliva, two-thirds (31/45, 69%) had tumours located in the oral cavity and 18/40 (45%) had the highest rates of free flap use during surgery. Salivation response was associated strongly with the other measures of health-related quality of life (HRQoL) and the PCI. Of those with too much saliva their results were similar to or worse than those with too little or no saliva at all. In conclusion, having too much saliva is relatively less frequently reported but is an important HRQoL consideration. Its scoring in the UW-QoL should be at a level similar to that of too little saliva. The aim of this paper is to report the clinical characteristic of those patients reporting “I have too much saliva” following treatment for head and neck cancer. As a new addition to the saliva question of the University of Washington quality of life questionnaire (UW-QoL), another aim is to make recommendations on how this new option should be scored and handled. Patients treated with curative intent were recruited between April 2017 and October 2019. Assessment was at the first baseline clinic a median (IQR) of 194 (125–249) days after diagnosis and 103 (71–162) days after the end of treatment. Patients completed the modified UW-QoL version 4, the Patient Concerns Inventory (PCI), Distress Thermometer, and the EQ-5D-5L. In 288 patients, saliva was of normal consistency for 80 (28%), less than normal but enough for 57 (20%), too little for 91 (32%), too much for 45 (16%), and there was no saliva at all for 15 (5%). Of patients with too much saliva, two-thirds (31/45, 69%) had tumours located in the oral cavity and 18/40 (45%) had the highest rates of free flap use during surgery. Salivation response was associated strongly with the other measures of health-related quality of life (HRQoL) and the PCI. Of those with too much saliva their results were similar to or worse than those with too little or no saliva at all. In conclusion, having too much saliva is relatively less frequently reported but is an important HRQoL consideration. Its scoring in the UW-QoL should be at a level similar to that of too little saliva. EQ-5D Elsevier Questionnaire Elsevier UW-QOL Elsevier Head and neck cancer Elsevier Saliva Elsevier Quality of life Elsevier Lowe, Derek oth Kanatas, Anastasios oth N Rogers, Simon oth Enthalten in Elsevier Dong, Zhiqiang ELSEVIER Bond durability of BFRP bars embedded in concrete under seawater conditions and the long-term bond strength prediction 2016transfer abstract Amsterdam [u.a.] (DE-627)ELV013958291 volume:58 year:2020 number:9 pages:51-56 extent:6 https://doi.org/10.1016/j.bjoms.2020.05.033 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_40 AR 58 2020 9 51-56 6 58.2020, 9, e51-, (6 S.) |
| language |
English |
| source |
Enthalten in Bond durability of BFRP bars embedded in concrete under seawater conditions and the long-term bond strength prediction Amsterdam [u.a.] volume:58 year:2020 number:9 pages:51-56 extent:6 |
| sourceStr |
Enthalten in Bond durability of BFRP bars embedded in concrete under seawater conditions and the long-term bond strength prediction Amsterdam [u.a.] volume:58 year:2020 number:9 pages:51-56 extent:6 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
EQ-5D Questionnaire UW-QOL Head and neck cancer Saliva Quality of life |
| dewey-raw |
600 |
| isfreeaccess_bool |
false |
| container_title |
Bond durability of BFRP bars embedded in concrete under seawater conditions and the long-term bond strength prediction |
| authorswithroles_txt_mv |
Broderick, Damian @@aut@@ Lowe, Derek @@oth@@ Kanatas, Anastasios @@oth@@ N Rogers, Simon @@oth@@ |
| publishDateDaySort_date |
2020-01-01T00:00:00Z |
| hierarchy_top_id |
ELV013958291 |
| dewey-sort |
3600 |
| id |
ELV052172236 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV052172236</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230626032928.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210910s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.bjoms.2020.05.033</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001214.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV052172236</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0266-4356(20)30257-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">600</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">690</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Broderick, Damian</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">How much of a problem is too much saliva for patients following head and neck cancer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The aim of this paper is to report the clinical characteristic of those patients reporting “I have too much saliva” following treatment for head and neck cancer. As a new addition to the saliva question of the University of Washington quality of life questionnaire (UW-QoL), another aim is to make recommendations on how this new option should be scored and handled. Patients treated with curative intent were recruited between April 2017 and October 2019. Assessment was at the first baseline clinic a median (IQR) of 194 (125–249) days after diagnosis and 103 (71–162) days after the end of treatment. Patients completed the modified UW-QoL version 4, the Patient Concerns Inventory (PCI), Distress Thermometer, and the EQ-5D-5L. In 288 patients, saliva was of normal consistency for 80 (28%), less than normal but enough for 57 (20%), too little for 91 (32%), too much for 45 (16%), and there was no saliva at all for 15 (5%). Of patients with too much saliva, two-thirds (31/45, 69%) had tumours located in the oral cavity and 18/40 (45%) had the highest rates of free flap use during surgery. Salivation response was associated strongly with the other measures of health-related quality of life (HRQoL) and the PCI. Of those with too much saliva their results were similar to or worse than those with too little or no saliva at all. In conclusion, having too much saliva is relatively less frequently reported but is an important HRQoL consideration. Its scoring in the UW-QoL should be at a level similar to that of too little saliva.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The aim of this paper is to report the clinical characteristic of those patients reporting “I have too much saliva” following treatment for head and neck cancer. As a new addition to the saliva question of the University of Washington quality of life questionnaire (UW-QoL), another aim is to make recommendations on how this new option should be scored and handled. Patients treated with curative intent were recruited between April 2017 and October 2019. Assessment was at the first baseline clinic a median (IQR) of 194 (125–249) days after diagnosis and 103 (71–162) days after the end of treatment. Patients completed the modified UW-QoL version 4, the Patient Concerns Inventory (PCI), Distress Thermometer, and the EQ-5D-5L. In 288 patients, saliva was of normal consistency for 80 (28%), less than normal but enough for 57 (20%), too little for 91 (32%), too much for 45 (16%), and there was no saliva at all for 15 (5%). Of patients with too much saliva, two-thirds (31/45, 69%) had tumours located in the oral cavity and 18/40 (45%) had the highest rates of free flap use during surgery. Salivation response was associated strongly with the other measures of health-related quality of life (HRQoL) and the PCI. Of those with too much saliva their results were similar to or worse than those with too little or no saliva at all. In conclusion, having too much saliva is relatively less frequently reported but is an important HRQoL consideration. Its scoring in the UW-QoL should be at a level similar to that of too little saliva.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">EQ-5D</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Questionnaire</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">UW-QOL</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Head and neck cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Saliva</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Quality of life</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lowe, Derek</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kanatas, Anastasios</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">N Rogers, Simon</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Dong, Zhiqiang ELSEVIER</subfield><subfield code="t">Bond durability of BFRP bars embedded in concrete under seawater conditions and the long-term bond strength prediction</subfield><subfield code="d">2016transfer abstract</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV013958291</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:58</subfield><subfield code="g">year:2020</subfield><subfield code="g">number:9</subfield><subfield code="g">pages:51-56</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.bjoms.2020.05.033</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">58</subfield><subfield code="j">2020</subfield><subfield code="e">9</subfield><subfield code="h">51-56</subfield><subfield code="g">6</subfield><subfield code="y">58.2020, 9, e51-, (6 S.)</subfield></datafield></record></collection>
|
| author |
Broderick, Damian |
| spellingShingle |
Broderick, Damian ddc 600 ddc 690 Elsevier EQ-5D Elsevier Questionnaire Elsevier UW-QOL Elsevier Head and neck cancer Elsevier Saliva Elsevier Quality of life How much of a problem is too much saliva for patients following head and neck cancer |
| authorStr |
Broderick, Damian |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV013958291 |
| format |
electronic Article |
| dewey-ones |
600 - Technology 690 - Buildings |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
600 VZ 690 VZ How much of a problem is too much saliva for patients following head and neck cancer EQ-5D Elsevier Questionnaire Elsevier UW-QOL Elsevier Head and neck cancer Elsevier Saliva Elsevier Quality of life Elsevier |
| topic |
ddc 600 ddc 690 Elsevier EQ-5D Elsevier Questionnaire Elsevier UW-QOL Elsevier Head and neck cancer Elsevier Saliva Elsevier Quality of life |
| topic_unstemmed |
ddc 600 ddc 690 Elsevier EQ-5D Elsevier Questionnaire Elsevier UW-QOL Elsevier Head and neck cancer Elsevier Saliva Elsevier Quality of life |
| topic_browse |
ddc 600 ddc 690 Elsevier EQ-5D Elsevier Questionnaire Elsevier UW-QOL Elsevier Head and neck cancer Elsevier Saliva Elsevier Quality of life |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
d l dl a k ak r s n rs rsn |
| hierarchy_parent_title |
Bond durability of BFRP bars embedded in concrete under seawater conditions and the long-term bond strength prediction |
| hierarchy_parent_id |
ELV013958291 |
| dewey-tens |
600 - Technology 690 - Building & construction |
| hierarchy_top_title |
Bond durability of BFRP bars embedded in concrete under seawater conditions and the long-term bond strength prediction |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV013958291 |
| title |
How much of a problem is too much saliva for patients following head and neck cancer |
| ctrlnum |
(DE-627)ELV052172236 (ELSEVIER)S0266-4356(20)30257-6 |
| title_full |
How much of a problem is too much saliva for patients following head and neck cancer |
| author_sort |
Broderick, Damian |
| journal |
Bond durability of BFRP bars embedded in concrete under seawater conditions and the long-term bond strength prediction |
| journalStr |
Bond durability of BFRP bars embedded in concrete under seawater conditions and the long-term bond strength prediction |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2020 |
| contenttype_str_mv |
zzz |
| container_start_page |
51 |
| author_browse |
Broderick, Damian |
| container_volume |
58 |
| physical |
6 |
| class |
600 VZ 690 VZ |
| format_se |
Elektronische Aufsätze |
| author-letter |
Broderick, Damian |
| doi_str_mv |
10.1016/j.bjoms.2020.05.033 |
| dewey-full |
600 690 |
| title_sort |
how much of a problem is too much saliva for patients following head and neck cancer |
| title_auth |
How much of a problem is too much saliva for patients following head and neck cancer |
| abstract |
The aim of this paper is to report the clinical characteristic of those patients reporting “I have too much saliva” following treatment for head and neck cancer. As a new addition to the saliva question of the University of Washington quality of life questionnaire (UW-QoL), another aim is to make recommendations on how this new option should be scored and handled. Patients treated with curative intent were recruited between April 2017 and October 2019. Assessment was at the first baseline clinic a median (IQR) of 194 (125–249) days after diagnosis and 103 (71–162) days after the end of treatment. Patients completed the modified UW-QoL version 4, the Patient Concerns Inventory (PCI), Distress Thermometer, and the EQ-5D-5L. In 288 patients, saliva was of normal consistency for 80 (28%), less than normal but enough for 57 (20%), too little for 91 (32%), too much for 45 (16%), and there was no saliva at all for 15 (5%). Of patients with too much saliva, two-thirds (31/45, 69%) had tumours located in the oral cavity and 18/40 (45%) had the highest rates of free flap use during surgery. Salivation response was associated strongly with the other measures of health-related quality of life (HRQoL) and the PCI. Of those with too much saliva their results were similar to or worse than those with too little or no saliva at all. In conclusion, having too much saliva is relatively less frequently reported but is an important HRQoL consideration. Its scoring in the UW-QoL should be at a level similar to that of too little saliva. |
| abstractGer |
The aim of this paper is to report the clinical characteristic of those patients reporting “I have too much saliva” following treatment for head and neck cancer. As a new addition to the saliva question of the University of Washington quality of life questionnaire (UW-QoL), another aim is to make recommendations on how this new option should be scored and handled. Patients treated with curative intent were recruited between April 2017 and October 2019. Assessment was at the first baseline clinic a median (IQR) of 194 (125–249) days after diagnosis and 103 (71–162) days after the end of treatment. Patients completed the modified UW-QoL version 4, the Patient Concerns Inventory (PCI), Distress Thermometer, and the EQ-5D-5L. In 288 patients, saliva was of normal consistency for 80 (28%), less than normal but enough for 57 (20%), too little for 91 (32%), too much for 45 (16%), and there was no saliva at all for 15 (5%). Of patients with too much saliva, two-thirds (31/45, 69%) had tumours located in the oral cavity and 18/40 (45%) had the highest rates of free flap use during surgery. Salivation response was associated strongly with the other measures of health-related quality of life (HRQoL) and the PCI. Of those with too much saliva their results were similar to or worse than those with too little or no saliva at all. In conclusion, having too much saliva is relatively less frequently reported but is an important HRQoL consideration. Its scoring in the UW-QoL should be at a level similar to that of too little saliva. |
| abstract_unstemmed |
The aim of this paper is to report the clinical characteristic of those patients reporting “I have too much saliva” following treatment for head and neck cancer. As a new addition to the saliva question of the University of Washington quality of life questionnaire (UW-QoL), another aim is to make recommendations on how this new option should be scored and handled. Patients treated with curative intent were recruited between April 2017 and October 2019. Assessment was at the first baseline clinic a median (IQR) of 194 (125–249) days after diagnosis and 103 (71–162) days after the end of treatment. Patients completed the modified UW-QoL version 4, the Patient Concerns Inventory (PCI), Distress Thermometer, and the EQ-5D-5L. In 288 patients, saliva was of normal consistency for 80 (28%), less than normal but enough for 57 (20%), too little for 91 (32%), too much for 45 (16%), and there was no saliva at all for 15 (5%). Of patients with too much saliva, two-thirds (31/45, 69%) had tumours located in the oral cavity and 18/40 (45%) had the highest rates of free flap use during surgery. Salivation response was associated strongly with the other measures of health-related quality of life (HRQoL) and the PCI. Of those with too much saliva their results were similar to or worse than those with too little or no saliva at all. In conclusion, having too much saliva is relatively less frequently reported but is an important HRQoL consideration. Its scoring in the UW-QoL should be at a level similar to that of too little saliva. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_40 |
| container_issue |
9 |
| title_short |
How much of a problem is too much saliva for patients following head and neck cancer |
| url |
https://doi.org/10.1016/j.bjoms.2020.05.033 |
| remote_bool |
true |
| author2 |
Lowe, Derek Kanatas, Anastasios N Rogers, Simon |
| author2Str |
Lowe, Derek Kanatas, Anastasios N Rogers, Simon |
| ppnlink |
ELV013958291 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth |
| doi_str |
10.1016/j.bjoms.2020.05.033 |
| up_date |
2024-07-06T22:17:47.389Z |
| _version_ |
1803869767482736640 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV052172236</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230626032928.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210910s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.bjoms.2020.05.033</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001214.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV052172236</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0266-4356(20)30257-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">600</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">690</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Broderick, Damian</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">How much of a problem is too much saliva for patients following head and neck cancer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The aim of this paper is to report the clinical characteristic of those patients reporting “I have too much saliva” following treatment for head and neck cancer. As a new addition to the saliva question of the University of Washington quality of life questionnaire (UW-QoL), another aim is to make recommendations on how this new option should be scored and handled. Patients treated with curative intent were recruited between April 2017 and October 2019. Assessment was at the first baseline clinic a median (IQR) of 194 (125–249) days after diagnosis and 103 (71–162) days after the end of treatment. Patients completed the modified UW-QoL version 4, the Patient Concerns Inventory (PCI), Distress Thermometer, and the EQ-5D-5L. In 288 patients, saliva was of normal consistency for 80 (28%), less than normal but enough for 57 (20%), too little for 91 (32%), too much for 45 (16%), and there was no saliva at all for 15 (5%). Of patients with too much saliva, two-thirds (31/45, 69%) had tumours located in the oral cavity and 18/40 (45%) had the highest rates of free flap use during surgery. Salivation response was associated strongly with the other measures of health-related quality of life (HRQoL) and the PCI. Of those with too much saliva their results were similar to or worse than those with too little or no saliva at all. In conclusion, having too much saliva is relatively less frequently reported but is an important HRQoL consideration. Its scoring in the UW-QoL should be at a level similar to that of too little saliva.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The aim of this paper is to report the clinical characteristic of those patients reporting “I have too much saliva” following treatment for head and neck cancer. As a new addition to the saliva question of the University of Washington quality of life questionnaire (UW-QoL), another aim is to make recommendations on how this new option should be scored and handled. Patients treated with curative intent were recruited between April 2017 and October 2019. Assessment was at the first baseline clinic a median (IQR) of 194 (125–249) days after diagnosis and 103 (71–162) days after the end of treatment. Patients completed the modified UW-QoL version 4, the Patient Concerns Inventory (PCI), Distress Thermometer, and the EQ-5D-5L. In 288 patients, saliva was of normal consistency for 80 (28%), less than normal but enough for 57 (20%), too little for 91 (32%), too much for 45 (16%), and there was no saliva at all for 15 (5%). Of patients with too much saliva, two-thirds (31/45, 69%) had tumours located in the oral cavity and 18/40 (45%) had the highest rates of free flap use during surgery. Salivation response was associated strongly with the other measures of health-related quality of life (HRQoL) and the PCI. Of those with too much saliva their results were similar to or worse than those with too little or no saliva at all. In conclusion, having too much saliva is relatively less frequently reported but is an important HRQoL consideration. Its scoring in the UW-QoL should be at a level similar to that of too little saliva.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">EQ-5D</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Questionnaire</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">UW-QOL</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Head and neck cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Saliva</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Quality of life</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lowe, Derek</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kanatas, Anastasios</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">N Rogers, Simon</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Dong, Zhiqiang ELSEVIER</subfield><subfield code="t">Bond durability of BFRP bars embedded in concrete under seawater conditions and the long-term bond strength prediction</subfield><subfield code="d">2016transfer abstract</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV013958291</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:58</subfield><subfield code="g">year:2020</subfield><subfield code="g">number:9</subfield><subfield code="g">pages:51-56</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.bjoms.2020.05.033</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">58</subfield><subfield code="j">2020</subfield><subfield code="e">9</subfield><subfield code="h">51-56</subfield><subfield code="g">6</subfield><subfield code="y">58.2020, 9, e51-, (6 S.)</subfield></datafield></record></collection>
|
| score |
7.401613 |